Recalled Drugs Tied to Heart Risk Spurs Call for FDA Review

Bloomberg -- Half of the 21 drugs pulled from the market in the U.S. for safety reasons since 1995 involved heart complications, a finding that is spurring Congress and doctors to call for closer government review of side effects.